• This Christmas, give your loved ones financial intelligence. Buy two copies of Value.able for the price of one this Christmas. Discount code: XMAS24 BUY NOW

Sirtex – a stronger result than we expected

Sirtex – a stronger result than we expected

We take a look at Sirtex Medical Limited’s half-year result to 31 December 2014. According to Portfolio Manager, Russell Muldoon, the result is much stronger across the board, than previously modeled, particularly in dosage sales (volumes), price increases and average selling prices.

Sirtex’s half-year result is further evidence of our current belief in the business’s underlying strength and management’s strategy.

EXCLUSIVE CONTENT

subscribe for free
or sign in to access the article

Sirtex is a major holding in both The Montgomery Fund and The Montgomery Private Fund.

This post was contributed by a representative of Montgomery Investment Management Pty Limited (AFSL No. 354564). The principal purpose of this post is to provide factual information and not provide financial product advice. Additionally, the information provided is not intended to provide any recommendation or opinion about any financial product. Any commentary and statements of opinion however may contain general advice only that is prepared without taking into account your personal objectives, financial circumstances or needs. Because of this, before acting on any of the information provided, you should always consider its appropriateness in light of your personal objectives, financial circumstances and needs and should consider seeking independent advice from a financial advisor if necessary before making any decisions. This post specifically excludes personal advice.

INVEST WITH MONTGOMERY

Why every investor should read Roger’s book VALUE.ABLE

NOW FOR JUST $49.95

find out more

SUBSCRIBERS RECEIVE 20% OFF WHEN THEY SIGN UP


2 Comments

  1. Great article Russell
    Looks like over time it will continue to forge ahead
    & even could get rocket if study is successful

    Could the Montgomery give us an update on Vocus
    I thought the H1 report was positive but shares went done ?
    The upcoming link with Amcon should also be positive?

Post your comments